Large cell neuroendocrine carcinoma of the lung: CT and FDG PET findings
- PMID: 26279139
- DOI: 10.1016/j.ejrad.2015.07.033
Large cell neuroendocrine carcinoma of the lung: CT and FDG PET findings
Abstract
Purpose: To evaluate the CT and (18)fluorine FDG PET findings of large cell neuroendocrine carcinomas (LCNECs) of the lung and to evaluate whether CT and FDG PET findings can help predict the clinical outcome.
Material and methods: Thirty-one patients (Male:Female=29:2; mean age, 69 years) who underwent surgical resection of an LCNEC of the lung were included in this retrospective study. The tumours were assessed with respect to morphologic characteristics and the maximum standardised uptake value (SUVmax) on pre-operative CT and FDG PET. For patients undergoing curative resection (n=26), disease-free survival was evaluated using the Kaplan-Meier test. The prognostic significance was assessed using a multivariate Cox proportional hazards regression analysis.
Results: The mean tumour diameter was 3.8 ± 2.1cm. Eight tumours (25.8%) were located centrally in the lung, and 23 (74.2%) were located peripherally. The margins were lobulated in 29 patients (93.5%) and well defined in 20 (64.5%). The mean SUVmax was 9.0 ± 3.8. The five-year disease-free survival rate was 46.3%. The shorter disease-free survival was related to the TNM stage greater than stage I, no lobulated margin of a tumour, a SUVmax >12.9 of a tumour, a long diameter >5.6 cm of a tumour, or female gender (P=0.115, P=0.134, P=0.056, P=0.168, P=0.113, respectively). The multivariate analysis indicated that a long diameter >5.6 cm (hazard ratio, 9.265; 90% confidence interval (CI), 1.996-42.992; P=0.017), female gender (hazard ratio, 5.579; 90% CI, 1.398-22.264; P=0.041), no lobulated margin (hazard ratio, 9.955; 90% CI, 1.433-69.136; P=0.051), and SUVmax >12.9 (hazard ratio, 4.062; 90% CI, 1.235-13.368; P=0.053) were independent predictors of shorter disease-free survival.
Conclusions: LCNECs of the lung more commonly occurred peripherally and exhibited well-defined and lobulated margins on CT. The mean SUVmax was consistent with malignant tumours. Female gender, a larger tumour diameter, no lobulated margin, and higher SUVmax were poor prognostic factors.
Keywords: (18)Fluorine fluorodeoxyglucose positron emission tomography; CT; Computed tomography; FDG PET; Large cell neuroendocrine carcinoma of the lung.
Copyright © 2015 Elsevier Ireland Ltd. All rights reserved.
Similar articles
-
Adenosquamous carcinoma of the lung: CT, FDG PET, and clinicopathologic findings.Clin Nucl Med. 2014 Feb;39(2):107-12. doi: 10.1097/RLU.0b013e3182952c2d. Clin Nucl Med. 2014. PMID: 23751831
-
Prognostic evaluations of small size lung cancers by 18F-FDG PET/CT and thin-section CT.Lung Cancer. 2014 Nov;86(2):180-4. doi: 10.1016/j.lungcan.2014.09.006. Epub 2014 Sep 16. Lung Cancer. 2014. PMID: 25263854
-
[Analysis of the Role of PET/CT SUVmax in Prognosis and Its Correlation with Clinicopathological Characteristics in Resectable Lung Squamous Cell Carcinoma].Zhongguo Fei Ai Za Zhi. 2016 Apr 20;19(4):192-9. doi: 10.3779/j.issn.1009-3419.2016.04.03. Zhongguo Fei Ai Za Zhi. 2016. PMID: 27118646 Free PMC article. Chinese.
-
The prognostic value of SUVmax measuring on primary lesion and ALN by 18F-FDG PET or PET/CT in patients with breast cancer.Eur J Radiol. 2018 Aug;105:1-7. doi: 10.1016/j.ejrad.2018.05.014. Epub 2018 May 17. Eur J Radiol. 2018. PMID: 30017264 Review.
-
Hyperaccumulation of (18)F-FDG in order to differentiate solid pseudopapillary tumors from adenocarcinomas and from neuroendocrine pancreatic tumors and review of the literature.Hell J Nucl Med. 2013 May-Aug;16(2):97-102. doi: 10.1967/s002449910084. Epub 2013 May 20. Hell J Nucl Med. 2013. PMID: 23687644 Review.
Cited by
-
Pulmonary large cell carcinoma with neuroendocrine morphology shows genetic similarity to large cell neuroendocrine carcinoma.Diagn Pathol. 2022 Feb 10;17(1):26. doi: 10.1186/s13000-022-01204-9. Diagn Pathol. 2022. PMID: 35144629 Free PMC article.
-
Pulmonary Combined Large Cell Neuroendocrine Carcinoma.Pathol Oncol Res. 2022 Nov 23;28:1610747. doi: 10.3389/pore.2022.1610747. eCollection 2022. Pathol Oncol Res. 2022. PMID: 36507119 Free PMC article. Review.
-
Large Cell Neuroendocrine Carcinoma of the Lung: Current Understanding and Challenges.J Clin Med. 2022 Mar 7;11(5):1461. doi: 10.3390/jcm11051461. J Clin Med. 2022. PMID: 35268551 Free PMC article. Review.
-
Thymic large cell neuroendocrine carcinoma - a rare and aggressive tumor: a case report.J Med Case Rep. 2017 Jun 12;11(1):155. doi: 10.1186/s13256-017-1331-2. J Med Case Rep. 2017. PMID: 28602157 Free PMC article.
-
Pulmonary Large Cell Neuroendocrine Carcinoma.Pathol Oncol Res. 2022 Oct 11;28:1610730. doi: 10.3389/pore.2022.1610730. eCollection 2022. Pathol Oncol Res. 2022. PMID: 36304941 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical